CDC, ACIP approve Novavax COVID-19 vaccine under emergency use authorization

OKLAHOMA CITY –– This week, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation of the Novavax COVID-19 vaccine for primary series vaccination in adults ages 18 and older.

Novavax is a two-dose, protein-based COVID-19 vaccine, adding another option to the Pfizer and Moderna mRNA vaccines and the Johnson & Johnson …